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Crohn’s disease (CD) is a chronic transmural disease process with approximately 10% of
patients developing spontaneous intra-abdominal abscess during the ﬁrst 5 years after
the diagnosis. The symptoms are often nonspeciﬁc. The treatment modalities include the
use  of wide-spectrum antibiotics, imaging-guided percutaneous drainage (PD) and surgical
drainage with or without resection. The best initial treatment strategy has not been settled
controversial, as there are only retrospective studies with small sample sizes available in
the literature. The majority of the patients would eventually need surgery. However a highly
selected patient population with small abscess in the absence of ﬁstulas or bowel strictures,
especially those naive to immunomodulators or biologics, may respond to medical treat-
ment alone with wide-spectrum antibiotics. The increased use of PD drainage in the last few
years  has been shown to reduce postoperative morbidities and risk of fecal diversion, allow-
ing  for subsequent elective surgery. Varied success rates of PD drainage have been reported
in  the literature. The initial surgical intervention of CD-related spontaneous abdominal sep-
sis  is mandatory in patients with diffuse peritonitis due to free perforation. Surgery is also
indicated in those with failed initial medical treatment and/or PD. This review article was
aimed to evaluate the treatment modalities for spontaneous intra-abdominal abscess in CD
patients and propose an algorithm for the best management of this complication.
©  2016 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda. This
is  an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
Tratamento  atual  de  abscesso  intra-abdominal  espontâneo  na  doenc¸a de
Crohn
r  e  s  u  m  oPlease cite this article in press as: Carvalho AT, et al. Current management of spontaneous intra-abdominal abscess in Crohn’s disease. J
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alavras-chave:
oenc¸a de Crohn
bscesso abdominal
A doenc¸a de Crohn (DC) é um processo patológico transmural crônico, em que aproximada-
mente 10% dos pacientes desenvolvem um abscesso intra-abdominal espontâneo durante
os  primeiros 5 anos após o diagnóstico. Com frequência os sintomas são inespecíﬁcos.
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Tratamento
Drenagem percutânea
Tratamento cirúrgico
As modalidades terapêuticas são o uso de antibióticos de amplo espectro, drenagem per-
cutânea (DP) orientada por imagem, e drenagem cirúrgica com ou sem ressecc¸ão. A melhor
estratégia terapêutica inicial ainda não ﬁcou estabelecida e há controvérsias, visto que a lit-
eratura conta apenas com estudos retrospectivos com pequenas amostras. Em sua maioria,
os  pacientes acabarão necessitando de cirurgia. Mas uma populac¸ão altamente selecionada
de  pacientes, com pequeno abscesso na ausência de fístulas ou constric¸ões intestinais,
especialmente aqueles que jamais foram medicados com imunomoduladores ou agentes
biológicos, podem responder exclusivamente ao tratamento clínico com antibióticos de
amplo espectro. Foi demonstrado que o uso mais frequente da DP nos últimos anos diminui
as  morbidades pós-operatórias e o risco de desvio fecal, o que possibilita uma  subsequente
cirurgia eletiva. Na literatura, têm sido relatados percentuais de sucesso variados com a DP.
A  intervenc¸ão cirúrgica inicial para a sepse abdominal espontânea relacionada à DC é obri-
gatória em pacientes com peritonite difusa, devido à perfurac¸ão livre. Também há indicac¸ão
cirúrgica naqueles pacientes que não conseguiram obter sucesso com o tratamento clínico
inicial e/ou DP. Esse artigo de revisão teve por objetivo avaliar as modalidades terapêuticas
para o abscesso intra-abdominal espontâneo em pacientes com DC; além disso, propõe um
algoritmo para o melhor tratamento dessa complicac¸ão.
© 2016 Sociedade Brasileira de Coloproctologia. Publicado por Elsevier Editora Ltda. Este
e´  um artigo Open Access sob uma licenc¸a CC BY-NC-ND (http://creativecommons.org/Core  tip
Crohn’s disease (CD) is a transmural chronic illness
with approximately 10% of patients developing sponta-
neous intra-abdominal abscess within the ﬁrst 5 years
after the diagnosis. CD spontaneous intra-abdominal
abscess can be managed with broad-spectrum antibi-
otics, imaging-guided percutaneous drainage or surgical
therapy. The best strategy of treatment is controversial
because the current literature is based on retrospective
series. This review aims to discuss the role of different
treatment options for spontaneous abdominal abscess in
CD patients and propose an algorithm for management
this complication.
Introduction
Crohn’s disease (CD) is a chronic inﬂammatory disease pro-
cess that can affect any parts of the gastrointestinal tract, with
the terminal ileum being the most frequent location. Its etiol-
ogy is likely multifactorial. The Montreal Classiﬁcation deﬁnes
the phenotype in three categories: stricturing, penetrating and
non-stricturing/non-penetrating.1 A few retrospective studies
have shown a progression from inﬂammatory to penetrating
phenotype within 5 years after the diagnosis of CD, more  fre-
quent during the ﬁrst 2 years. Many  CD patients may present
with ﬁstulas during the disease course, due to the fact that
there is a transmural bowel involvement by CD. Approx-
imately 10% of the patients would develop spontaneousPlease cite this article in press as: Carvalho AT, et al. Current managem
Coloproctol (Rio J). 2016. http://dx.doi.org/10.1016/j.jcol.2016.05.003
intra-abdominal abscess.2 Spontaneous septic complications
are often detrimental to disease outcome as well as cost
to the healthcare system. Nonetheless, almost one third oflicenses/by-nc-nd/4.0/).
patients using immunomodulators and/or biological therapy
can develop spontaneous intra-abdominal abscesses.3,4
Intra-abdominal abscess is deﬁned as an extra-intestinal
infected ﬂuid collection on imaging studies. Spontaneous
abscess should not be misinterpreted as abscess from post-
operative complications. Therefore, an abscess presenting
within 3 months after surgery can be arbitrarily deﬁned as
postoperative complications and should not be considered or
treated as spontaneous abdominal abscess.
Symptoms of abdominal abscess can be unspeciﬁc. The
most common symptoms are abdominal pain, fever, diarrhea,
and nausea.3 The presence of acute peritonitis or free perfora-
tion from CD is rare. Spontaneous intra-abdominal abscesses
are frequently located in the right lower quadrant and they
can be exclusively in the abdomen, pelvis or the proximity of
psoas muscle. Patients with psoas abscess may present with
ﬂank or back pain and limp.
The management of intra-abdominal abscess used to
be interventional. The surgical modalities include abscess
drainage with or without bowel resection and with or without
the construction of a stoma. On the other hand, computerized
tomography (CT) or ultrasound (US) imaging-guided percuta-
neous drainage (PD) has recently gained popularity. The best
approach for CD-related intra-abdominal abscess has been
in debate. The European Crohn’s and Colitis Organization (ECCO)
recommends that a CD patient with a spontaneous intra-
abdominal abscess should be managed with broad-spectrum
antibiotics, imaging-guided percutaneous drainage or surgical
drainage followed by delayed resection if necessary.5 If abdom-
inal sepsis is contained, elective surgery should be performed.
Conservative medical management should not be considered,
if abdominal sepsis persists. However, the published litera-
ture has shown conﬂicting results. Ananthakrishnan et al.
analyzed the nationally representative hospitalization sampleent of spontaneous intra-abdominal abscess in Crohn’s disease. J
from more  than 1000 American hospitals, including 3296 adult
CD-related, non-elective hospitalizations that were compli-
cated by intra-abdominal abscesses. Approximately 39% were
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reated by medical treatment alone, 29% with PD, and 32% with
urgery, demonstrating an increase in the use of PD since 1998.
he presence of complicated CD (stricture or ﬁstulae) was
ssociated with an increased likelihood of surgical interven-
ion; and the admission to a teaching hospital was associated
ith an increased likelihood of PD, which may be credited to
he availability of local expertise. Early intervention, either
D or surgical approach, was associated with a shorter hos-
italization stay and lower costs.6 One of the limitations of
he study is that population studied were all inpatients and
atients with mild diseases or small abscessed might have
een treated as outpatient.
This review was aimed to discuss the role of medical
anagement in CD patients presenting with spontaneous
bdominal abscess, to describe the clinical outcomes of
maging-guided PD and to evaluate the surgical indications
n those patients.
edical  treatment
he use of wide-spectrum antibiotics targeting gram-negative
nd anaerobic bacteria is mandatory, once the diagnosis
f spontaneous abdominal abscess from CD is conﬁrmed.
iproﬂoxacin in combination with metronidazole for 7–21
ays is the most common choice. The third-generation
ephalosporin plus metronidazole and carbapenems can also
e prescribed. Retrospective studies have reported an efﬁcacy
f approximately 60% for abscess resolution with parental
ntibiotics alone. However, over 50% of the patients eventually
eeded surgery.7,8 Factors associated with failure in medical
herapy included corticosteroid use, the presence of ﬁstula
nd large abscess size. Small abscess without concurrent ﬁs-
ula had a higher chance of respond to antibiotics alone. This
s particularly true in those naive to the use of immunomod-
lators or biologics.3,7 The cut-off for size of abscess that
ould predict treatment response was not clearly identiﬁed.
owever, it is generally believed that abscess greater than
 cm usually would not respond to medical treatment alone
nd require drainage.9 Lee et al. have studied the nonsurgical
reatment of CD abscess in 24 patients (19 medical treatment
lone and 5 PD) with an overall success of 67%. Cumula-
ive recurrence rate was 12.5% and they all occurred within 7
onths from the complete resolution of abscess on follow-up
maging. Signiﬁcant factors that lead to failure of nonsurgical
reatment were the presence of ﬁstula and concurrent use of
orticosteroids.7
The use of corticosteroids during the management of
D-associated abscess management is controversial. Some
uthors advocated its use for concomitant severe inﬂamma-
ion in the bowel wall, which can be started after the ﬁrst
ose of intravenous antibiotics.3,10 In contrast, immunomod-
lator or biological therapy should not be initiated and should
e discontinued in the presence of abdominal abscess. Once
bscess resolution is conﬁrmed by imaging studies, we can
onsider the use of immunomodulator or biological therapy.Please cite this article in press as: Carvalho AT, et al. Current managem
Coloproctol (Rio J). 2016. http://dx.doi.org/10.1016/j.jcol.2016.05.003
owever, the presence of strictures and abdominal ﬁstulas
sually indicates the need of surgical treatment since there
ight be already an irreversible structural damage in the
owel wall.;x x x(x x):xxx–xxx 3
Few studies have compared medical, PD and surgical
management of CD abscess. Bermejo et al. published a retro-
spective multi-center study analyzing outcomes of different
treatment modalities of abdominal abscess during a 1-year
follow-up. Their deﬁnition of response was the resolution of
the abscess on imaging, and no clinical signs of recurrence
within 12 months follow-up. Of the 128 patients included,
the authors demonstrated treatment efﬁcacy of 63 percent, 30
percent and 91 percent for medical treatment alone, PD and
surgical approach, respectively. Predictors of poor response for
the medical treatment alone were the use of immunomod-
ulators, the presence of ﬁstula and large abscess size. No
predictors of successful treatment were found in the PD or
surgical group.3 Other studies reported the success of med-
ical treatment in small CD abscess in the absence of other
complications and immunomodulators naïve patients.
Imaging-guided  PD
The proper use of imaging-guided PD largely relies on the size
of abscess. The American College of Radiology recommends
imaging-guided PD for CD-related abdominal ﬂuid collections
greater than 4 cm.9 Reported efﬁcacy with PD in CD abdomi-
nal abscess ranged from 50% to 92%.8,11,12 This wide range of
success rates may be attributed to a variety of factors, includ-
ing the timing and techniques of PD and deﬁnitions of PD
failure.
Various techniques of PD have been described. The Seldinger
technique is the most common used for PD in CD patients
presenting with abdominal abscess. Of note, PD is not
always feasible for intra-abdominal abscess, particularly in
the presence of intra-mesenteric, interloop or multiloculated
abscess. Sometimes the small-caliber catheters may be easily
obstructed by necrotic tissue, blood coagulates and thick puru-
lent ﬂuid in the abscess cavity. In these cases, greater caliber
catheters could replace the small-sized drainage system. Liu
et al. have described a strategy using a sump drain with trocar
puncture and continuous irrigation and suction under nega-
tive pressure, in order to avoid blockage of the drainage system
and allow for faster resolution of abscess.13
The PD drainage followed by delayed elective surgery has
gained popularity. The rationale is the allowance for time
in the improvement of patient’s clinical and nutritional con-
ditions, “cool-down” or resolution of abscess or sepsis, and
reduction in postoperative morbidities and risk for stoma
creation.14
In selected patients, PD followed by proper medical treat-
ment may be effective in preventing recurrent abscess,
without the need of delayed surgery. Some retrospective
studies suggested that PD, when feasible, could deviate the
need of urgent surgery and the risk of subsequent sep-
tic complications. Nguyen et al. reviewed retrospectively 95
patients presenting with CD spontaneous abscess. Fifty-ﬁve
patients underwent CT- or ultrasound-guided PD followed
by the treatment with biological therapy with or withoutent of spontaneous intra-abdominal abscess in Crohn’s disease. J
concomitant immunomodulators and 40 patients underwent
initial surgery. The initial surgery group had an increased
length of hospital stay when compared with the PD plus bio-
logical therapy group (15.5 vs. 5 days), but there were no
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differences in abscess recurrence and complications. Abscess
recurrence was more  frequent within 30 days after treat-
ment and the risk factors for recurrence were perianal disease
and ileal active inﬂammation.15 This study suggests that
the initiation of anti-tumor necrosis factor and/or immuno-
suppressive therapy when abscesses resolve could protect
patients from developing intra-abdominal penetrating dis-
ease. In this study, biological therapy was started at the same
day of PD in some patients without other septic complications;
however, the optimal timing to start the biological therapy
is debatable. In authors’ opinion, the biological agent can
be started within one week after complete resolution of the
abscess.
It remains to be controversial and is not well deﬁned
whether PD alone can be the ﬁrst and sole treatment option in
CD-related abdominal abscess or it works as an interim pro-
cedure allowing subsequent elective surgery. Gutierrez et al.
have identiﬁed 66 patients with CD abdomino-pelvic abscess
treated at the Massachusetts General Hospital (29 with initial
surgery vs. 37 with PD). Even though the time to resolution of
abdominal or pelvic abscesses in CD was similar between both
treatment groups, only one-third of patients treated with PD
required surgery within 1 year.16 Lobatón et al. retrospectively
compared 22 CD patients with abdominal abscess who under-
went PD alone with 22 controls with immediate surgery. The
PD alone patients were only operated when there was PD fail-
ure. During a 1-year follow-up, only 27% of PD alone patients
were able to achieve durable abscess resolution and the other
two thirds have undergone surgical treatment. Abscess size,
multilocularity, presence of ﬁstula and use of corticosteroid
were not statistically associated with PD failure.11 In con-
trary, Garcia et al. have questioned the efﬁcacy of PD alone
in a retrospective study, which included 51 CD patients with
abdominal abscess during a 10-year period. Recurrent or new
abscess were more  frequent in the PD approach when com-
pared with the surgical approach (56% versus 12%), with a
median follow-up of 3.8 years.8 The debate will persist until
deﬁnite answer is obtained by large, randomized controlled
trials.
There are some contradictory results in whether PD fol-
lowed by delayed elective surgery can reduce morbidity as
compared with the approach with initial surgery. da Luz Mor-
eira et al. reported no signiﬁcant increase in postoperative
septic complication rate or length of hospital stay by the initial
surgery versus the initial PD followed by delayed surgery. How-
ever, elective surgery after successful PD achieved a reduced
rate of stoma creation when compared with initial surgery.
The reported factors associated with the failure of PD were
corticosteroid use, colonic phenotype, and multiple or multi-
locular abscesses, whereas abscess size did not preclude PD
success.12 Xie et al. have shown advantages of PD in a small
sample of CD patients. PD was performed using a contin-
uous irrigation and aspiration drainage by a speciﬁc device
named “three channel aspiration drainage,” which contains
a two-channel drainage with vacuum aspiration and a ﬂuid
inlet tube. The performance of PD was able to reduce post-Please cite this article in press as: Carvalho AT, et al. Current managem
Coloproctol (Rio J). 2016. http://dx.doi.org/10.1016/j.jcol.2016.05.003
operative complications and stoma creation, when compared
with the initial surgery group, but could not avoid subsequent
surgery.17 On the other hand, Braffors et al. have compared PD-
then-delayed surgery with the initial-surgery-alone approach6;x x x(x x):xxx–xxx
in 70 patients with CD abdomino-pelvic abscesses at Mount
Sinai Medical Center. PD was technically successful in 92% of
patients and clinically successful in 74%. They could not ﬁnd
any difference regarding postoperative septic complications
and stoma creation but there was an increased length of hos-
pital stay in the PD-then-delayed surgery group.18 Therefore,
it appears that surgery may be avoided in a small selected
group of patients with abscess resolution treated with PD
alone.
Surgical  treatment
The initial surgical treatment of spontaneous abdominal sep-
sis is the only option for patients with free perforation and
diffuses peritonitis. The approach is also indicated in those
patients who have failed the initial medical treatment and PD.
Surgical pathological examination of resected bowel speci-
mens has demonstrated the association between penetrating
disease and mechanical factors, such as luminal narrowing
of the bowel from ﬁbrotic stricture.19 These ﬁndings may
explain why the presence of stricture and ﬁstula is frequently
associated with the failure of nonsurgical approach and the
necessity of surgery with bowel resection.
The surgical approach has been addressed by two recent
meta-analyses, which showed results favoring the initial or
delayed surgery in CD abdominal abscess. The results demon-
strated that surgery appears to be inevitable in the majority of
the patients. Nguyen et al. have analyzed nine studies includ-
ing 603 patients. The overall rate of abscess resolution was
57% in the medical group as compared with 81% in the surgi-
cal group, suggesting that initial surgical management could
be superior to medical management.20 He et al. have looked
at other nine studies including 513 patients and could not
ﬁnd signiﬁcance difference in postoperative recurrent abscess
between the preoperative PD and initial surgery groups.21
Therefore, it is not clear whether the PD-then-elective surgery
approach is better than the initial surgery approach.
It is generally believed that urgent or semi-urgent surgery
for CD-associated abscess should be avoided, if possible.
Some authors proposed that a delayed surgery, within 6 to
8 weeks after antibiotic treatment and PD would not only
permit the optimization of clinical and nutritional status but
also provide the window for preoperative endoscopic and
imaging work-up to delineate the anatomy and avoid unex-
pected intraoperative ﬁndings. A study of 94 patients from
the Cleveland Clinic have shown that the PD-then-delayed
surgery gave higher quality-adjusted life-years, was more
cost-effective, and had lower risk for stoma creation.12 The
presence of enterocutaneous ﬁstula after PD was not consid-
ered a failure since all patients were submitted to elective
resection after sepsis control. Poritz et al. have proposed
a treatment algorithm to treat CD-associated spontaneous
abdominal abscess beginning with an initial percutaneous
drainage of the abscess, 5–7 days of IV antibiotics with
simultaneous high-dose corticosteroids and hyperalimenta-ent of spontaneous intra-abdominal abscess in Crohn’s disease. J
tion, followed by planned one-stage resection with primary
anastomosis. Nineteen consecutive patients were treated with
this protocol with acceptable morbidity and low rates of stoma
creation.22
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In patients undertaking the initial surgery approach, the
toma creation after bowel resection is usually required
n the presence of abdominal sepsis, with few exceptions.
any  patients with spontaneous CD abscess are nutritionally
epleted and are using various immunosuppressant medi-
ations, such as high-dose corticosteroids, azathioprine or
nti-TNF agents. Yamamoto et al. reported that a low pre-
perative albumin level, corticosteroid use, and abscess or
ny ﬁstula at the time of surgery were associated with post-
perative septic complications. The risk for sepsis was as
igh as 50% when all factors were present.23 Stoma creation
as aimed to reduce postoperative complications, despite a
earth of evidence on this topic. The indications for loop cov-
ring stoma or split stomas are at the surgeon’s discretion
or this high-risk group of patients. Some surgeons believed
hat loop stomas might not completely avoid anastomotic leak
ut could minimize adverse consequences of this complica-
ion and facilitate staged stoma closure. Merge  et al. reviewed
0 CD patients that underwent stoma creation, including 63
plit stomas and 17 covering loop ileostomies and found that
emporary fecal diversion was beneﬁcial in high-risk patients
fter ileocolonic resection despite a 19% rate of postoperative
omplications.24
Finally, there is a lack of data on laparoscopic surgery for
D patients with penetrating disease. In selective cases, it is
easible to performed drainage and resection by minimallyPlease cite this article in press as: Carvalho AT, et al. Current managem
Coloproctol (Rio J). 2016. http://dx.doi.org/10.1016/j.jcol.2016.05.003
nvasive techniques. Whether initial or delayed surgery can
e performed safely by laparoscopic approach it is still to be
etermined.
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Conclusions
Current data shows that for adult CD patients with sponta-
neous abdominal abscess:
• Small abscesses can be treated with antibiotics alone;
• Large abscesses should be drained with image-guided PD if
feasible;
• In a highly selected group of patients without obstruc-
ting symptoms or abdominal ﬁstulas, medical treatment
or PD alone could be successful in preventing recurrent
abscess;
• The majority of patients will eventually need surgery;
• Initial surgical drainage is effective in most cases however
it can increase postoperative morbidity;
• PD followed by delayed elective surgery appears to decrease
morbidity and avoid stoma creation;
It is important to emphasize that current literature is based
in retrospective studies with bias, issue of sample sizes, and
some contradictory results. The deﬁnition of treatment suc-
cess is also heterogeneous and some studies suffer from a
short follow-up. Prospective and larger studies are necessary
to better understand the impact of CD spontaneous sepsis
in the healthcare system and to choose the best treatmentent of spontaneous intra-abdominal abscess in Crohn’s disease. J
options in different clinical scenarios. A suggested algorithm
for CD spontaneous abscess management is presented in
Fig. 1.
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tive inﬂammation in the bowel wall.
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